Disable Preloader

Pituitary surgery

Surgically treatable diseases of the pituitary gland and surrounding structures have played an important role in neurosurgery at the UKE for over 35 years. The pituitary surgery division of the UKE is one of the two largest in Germany, treating tumors in more than 270 patients per year.

About 80% of these surgeries are performed on pituitary adenomas such as hormone-inactive adenomas, Cushing’s syndrome, acromegaly, and TSH-producing tumors. Twenty percent of operations involve other pathologies such as craniopharyngioma or metastases. When possible we offer the patient transnasal surgery, as this technique provides better results at lower risk. Increasingly, transnasal skull base surgery is used for treatment of skull base disorders. The success rate for microadenomas (<1 cm) is above 90%, and that for macroadenomas is up to 65% for complete tumor removal and cure. The risk of severe surgical complications is less than 1%.

Patients receive interdisciplinary pre- and postoperative care in collaboration with endocrinologists. This ensures optimal care during the hospital stay. The UKE engages in all state-of-the-art procedures necessary for your treatment, including hormone measurements, MR imaging, angiography, intraoperative doppler ultrasonography, microsurgery, endoscopy, neuronavigation, neuropathology, and neuroanesthesia. An ultra-modern surgery wing and an intensive care unit are available around the clock.

Medical colleagues can conduct case conferences via video to determine specific procedures.

If an operation is required, a time for inpatient admission is determined. Usually you stay at the hospital as an inpatient for about 7 days. On Day 1 – if no additional tests are required – the neurosurgical and anesthetic consultations as well as a physical examination and a blood draw will take place. On Day 2 the surgery will be performed. On the following days you recover from surgery, and blood and hormone tests are performed along with a new MRI scan, if necessary. Then you may travel back home.

Please direct your treatment request to the UKE International Office.

Access is only allowed for visitors and accompanying persons properly wearing FFP2 masks and who show:
• No typical symptoms,
• No SARS-CoV-2 infection, AND
• A negative result from a current test (PCR no older than 48 hours, rapid antigen no older than 24 hours)
Please also pay attention to any further information and signage!

In cooperation with

We are certified